AIToday
AI in HealthcareHacker NewsPublished: Aug 11, 2026, 01:01 JST

AI tool shrinks proteins by 10–15% while preserving function

AI tool shrinks proteins by 10–15% while preserving function

3 Key Points

  1. What happened

    Researchers at Duke University have developed an AI program called Raygun that can suggest cuts to a protein's amino acid sequence, reducing overall size without losing function. The tool shrank fluorescent proteins EGFP and mCherry by 10–15%, and the resulting proteins still glowed under excitation.

  2. Why it matters

    Smaller proteins could reduce interference when tagging biological processes, and shrinking sequences may help gene therapy by fitting into the limited capacity of delivery vehicles like adeno-associated viruses. The approach works by learning from evolutionary patterns in protein sequences to identify critical pieces, rather than testing mutations one at a time.

  3. What to watch

    The tool can also expand proteins, which researchers are still developing—a capability that could help add new domains to existing proteins. Raygun is not positioned as a replacement for de novo protein design (creating proteins from scratch) but rather as a complement; both techniques could be used together.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Context & Analysis

Raygun represents a distinct strategy in protein engineering: rather than designing proteins entirely from scratch, it works within the boundaries of known protein sequences, using AI to identify which amino acids are truly essential and which can be removed or substituted. This approach, led by computational biologist Rohit Singh at Duke University, harnesses evolutionary patterns embedded in protein sequences to guide the search for critical components—a method that allows for more extensive modifications than traditional point-by-point mutation testing would suggest.

The practical implications align with real bottlenecks in biotechnology. Gene therapy faces a fundamental constraint: viral delivery vehicles have limited carrying capacity, and any reduction in the size of a therapeutic protein could expand the range of candidates. Similarly, fluorescent protein tags, while invaluable for imaging biological processes, can sometimes alter the very systems they are meant to observe; miniaturizing them could mitigate this interference. Singh's team views Raygun not as a replacement for de novo design but as a complementary tool that can operate on top of newly engineered proteins, effectively allowing researchers to refine and optimize novel designs further.

FAQ
How much did Raygun shrink the test proteins?
The tool shrank fluorescent proteins EGFP and mCherry by 10–15%, and the resulting proteins still glowed under excitation.
How is Raygun different from designing proteins from scratch?
De novo design creates entirely new proteins; Raygun explores the space around an existing protein more effectively by learning from evolutionary patterns. The two approaches could even be used together—applying Raygun to a newly designed protein to explore variants of it.

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleZuckerberg's 6,500-word AI essay: open models, data centers, less regulation